Vivos Therapeutics (VVOS) Net Cash Flow (QoQ) (2020 - 2026)
Analysis
Vivos Therapeutics (VVOS) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Align Technology | 11.30 Bn | 10.20 Bn | 757.43 Mn |
| 2 | Envista Holdings | 4.38 Bn | 3.26 Bn | 407.00 Mn |
| 3 | Dentsply Sirona | 2.27 Bn | 2.03 Bn | 493.00 Mn |
| 4 | Milestone Scientific | 37.81 Mn | 35.20 Mn | 1.56 Mn |
| 5 | Dror Ortho-Design | 9.77 Mn | 9.68 Mn | - |
| 6 | Vivos Therapeutics | 2.76 Mn | 790,007.20 | 2.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -566.67% |
| Mar 31, 2026 | 107.74% |
| Dec 31, 2025 | 22.75% |
| Sep 30, 2025 | 85.60% |
| Jun 30, 2025 | -139.83% |
| Mar 31, 2025 | -35,554.55% |
| Dec 31, 2024 | 98.18% |
| Sep 30, 2024 | -114.22% |
| Jun 30, 2024 | 339.67% |
| Mar 31, 2024 | 47.34% |
| Dec 31, 2023 | 122.24% |
| Sep 30, 2023 | 4.89% |
| Jun 30, 2023 | -188.06% |
| Mar 31, 2023 | 210.22% |
| Dec 31, 2022 | 46.26% |
| Sep 30, 2022 | -15.65% |
| Jun 30, 2022 | 17.22% |
| Mar 31, 2022 | -38.10% |
| Dec 31, 2021 | 19.84% |
| Sep 30, 2021 | -127.91% |